Literature DB >> 9591773

Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.

G Posern1, J Zheng, B S Knudsen, C Kardinal, K B Müller, J Voss, T Shishido, D Cowburn, G Cheng, B Wang, G D Kruh, S K Burrell, C A Jacobson, D M Lenz, T J Zamborelli, K Adermann, H Hanafusa, S M Feller.   

Abstract

Many Src Homology 3 (SH3) domains function as molecular adhesives in intracellular signal transduction. Based on previous ultrastructural studies, short motifs which bind to the first SH3 domains of the adapters Crk and CRKL were selectively mutagenised to generate Crk/CRKL SH3-binding peptides of very high affinity and selectivity. Affinities were increased up to 20-fold compared to the best wildtype sequences, while the selectivity against a similar SH3 domain [Grb2SH3(N)] was not only retained, but sometimes increased. Blot techniques with GST-fusion peptides and in solution precipitation assays with biotinylated high affinity Crk binding peptides (HACBPs) were subsequently used to analyse the binding of these sequences to a large panel of SH3 domain-containing fusion proteins. Only those proteins which contained the CrkSH3(1) or CRKLSH3(1) domains bound efficiently to the HACBPs. A GST-HACBP fusion protein precipitated Crk and CRKL proteins out of 35S-labelled and unlabelled cell lysates. Very little binding of other cellular proteins to HACBP was detectable, indicative of a great preference for Crk and CRKL when compared to the wide variety of other endogenous cellular proteins. Moreover, HACBP disrupted in vitro preexisting Crk-complexes with DOCK180 and the exchange factors SoS and C3G, which are known targets of Crk adapters, in a concentration dependent manner. HACBP-based molecules should therefore be useful as highly selective inhibitors of intracellular signalling processes involving Crk and CRKL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591773     DOI: 10.1038/sj.onc.1201714

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Mutant actins that stabilise F-actin use distinct mechanisms to activate the SRF coactivator MAL.

Authors:  Guido Posern; Francesc Miralles; Sebastian Guettler; Richard Treisman
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

2.  Directed discovery of bivalent peptide ligands to an SH3 domain.

Authors:  Monique R Ferguson; Xiuzhen Fan; Munia Mukherjee; Jinquan Luo; Raza Khan; Josephine C Ferreon; Vincent J Hilser; Robert E Shope; Robert O Fox
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

3.  Application of ring-closing metathesis to Grb2 SH3 domain-binding peptides.

Authors:  Fa Liu; Alessio Giubellino; Philip C Simister; Wenjian Qian; Michael C Giano; Stephan M Feller; Donald P Bottaro; Terrence R Burke
Journal:  Biopolymers       Date:  2011       Impact factor: 2.505

4.  Structural characterization of Lyn-SH3 domain in complex with a herpesviral protein reveals an extended recognition motif that enhances binding affinity.

Authors:  Finn Bauer; Kristian Schweimer; Heike Meiselbach; Silke Hoffmann; Paul Rösch; Heinrich Sticht
Journal:  Protein Sci       Date:  2005-09-09       Impact factor: 6.725

5.  Biochemistry on a leash: the roles of tether length and geometry in signal integration proteins.

Authors:  David Van Valen; Mikko Haataja; Rob Phillips
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

6.  Role of interfacial water molecules in proline-rich ligand recognition by the Src homology 3 domain of Abl.

Authors:  Andres Palencia; Ana Camara-Artigas; M Teresa Pisabarro; Jose C Martinez; Irene Luque
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

7.  Protease-based synthetic sensing and signal amplification.

Authors:  Viktor Stein; Kirill Alexandrov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-29       Impact factor: 11.205

8.  Engineering robust control of two-component system phosphotransfer using modular scaffolds.

Authors:  Weston R Whitaker; Stephanie A Davis; Adam P Arkin; John E Dueber
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

9.  Herpesvirus ateles gene product Tio interacts with nonreceptor protein tyrosine kinases.

Authors:  J C Albrecht; U Friedrich; C Kardinal; J Koehn; B Fleckenstein; S M Feller; B Biesinger
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

10.  Models of crk adaptor proteins in cancer.

Authors:  Emily S Bell; Morag Park
Journal:  Genes Cancer       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.